Siren »

Alumis shares owned by Siren

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Siren from 13F filings

Historical chart of Siren investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Siren

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 500k 9.76

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Olema Pharmaceuticals (OLMA)
Disc Medicine (IRON)
Structure Therapeutics Sponsored Ads (GPCR)
Tango Therapeutics (TNGX)
Arcus Biosciences Incorporated (RCUS)
Stoke Therapeutics (STOK)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Siren

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
BlackRock
Foresite Capital Management VI
Vanguard Group
Cormorant Asset Management
Saturn V Capital Management
Nextech Invest
Octagon Capital Advisors
MPM Oncology Impact Management
Sr One Capital Management
Baker Bros. Advisors
Geode Capital Management

View all funds holding Alumis